ClinicalTrials.gg
Drug

Vilanterol clinical trials

Also written GW642444.

studies test it
79
open now
4
in phase 3
33
first study started
2005

How each study uses vilanterol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the vilanterol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
13 Nov 2013 · Relvar Ellipta · EMEA/H/C/002673 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vilanterol
10
FF/GW642444 Inhalation Powder
4
GW642444 Inhalation Powder
4
Placebo
2
GW642444 25
2

Development codes

GW642444
11

In one entry with another drug

Given together, or one or the other

FF/UMEC/VI
10
Fluticasone Furoate/Vilanterol
9
Trelegy
4
FF/VI
3
Umeclidinium/vilanterol
2
Vilanterol and Fluticasone Furoate
2
Fluticasone Furoate/GW642444
2
Inhaled GSK573719/vilanterol
2

Studies by the year they started

79 studies that test it; most in 2010 (12)

Studies that test vilanterol, by start year
YearStudies
20051
20062
20089
20095
201012
201110
20129
20132
20143
20151
20162
20172
20186
20192
20213
20222
20235
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
16
Phase 2
11
Phase 3
33
Phase 4
16
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 67 · Other 12

GlaxoSmithKline (67) · Morten Hostrup, PhD (2) · Samsung Medical Center (1) · Dr. Grace Parraga (1) · Luis Puente Maestu (1) · Thammasat University (1) · Rambam Health Care Campus (1) · University of Dundee (1)

Often tested with

Tested in the same studies.

Fluticasone furoate (33) · Fluticasone (33) · GSK573719 (22) · Tiotropium (3) · Darotropium bromide (3) · GW685698 (3) · Umeclidinium bromide (2) · Glycopyrrolate (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test vilanterol, phase 3 first.

Studies

Open first, then newest update. How each study uses vilanterol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 79

See all 79 studies that test vilanterol →

Given beside what is tested · 5 — vilanterol is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with vilanterol

Codes

What other systems call vilanterol · ClinicalTrials.gg INT005657

  • MeSH (NLM) C550468vilanterolOne source NLM
  • UNII (FDA) 028LZY775BVILANTEROLConfirmed FDA, NLM, Wikidata
  • RxNorm 1424884Confirmed FDA, Wikidata
  • Wikidata Q15053666vilanterolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152875VilanterolOne source FDA
  • DrugBank DB09082One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.